Last reviewed · How we verify
Placebo (for D377) — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo (for D377) (Placebo (for D377)) — Chong Kun Dang Pharmaceutical. Placebo has no active pharmacological mechanism and serves as a control comparator in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo (for D377) TARGET | Placebo (for D377) | Chong Kun Dang Pharmaceutical | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo (for D377) CI watch — RSS
- Placebo (for D377) CI watch — Atom
- Placebo (for D377) CI watch — JSON
- Placebo (for D377) alone — RSS
Cite this brief
Drug Landscape (2026). Placebo (for D377) — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-for-d377. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing